id,collection,Authors,Date,Description,Language,Link to other languages,MeSH Headings,MeSH qualifiers,Publication place,Publisher,Subject or keywords,Title,Type,dc.date.accessioned,dc.date.available,dc.identifier.govdoc,dc.identifier.uri "21218","10665/19979","Assemblée mondiale de la Santé, 57","2004","Cinquante-septième Assemblée mondiale de la Sante, Point 12.12 de l’ordre du jour provisoire, 3 p.","fr","10665/22413||10665/21235||10665/22902||10665/20909||10665/20091","Drug Industry::Drug Industry::600||Drug Monitoring::Drug Monitoring::600||Pharmaceutical Preparations::Pharmaceutical Preparations::600||Blood::Blood::600||Blood Substitutes::Blood Substitutes::600||Commerce::Commerce::600||Interinstitutional Relations::Interinstitutional Relations::600","normes||législation et jurisprudence","Genève, Suisse","Organisation mondiale de la Santé","Produits pharmaceutiques et médicaments||Sécurité des transfusions sanguines","Qualité et innocuité des médicaments : systèmes de réglementation : rapport du secrétariat","Governing body documents","2012-02-29T09:50:05Z","2012-02-29T09:50:05Z","A57/15","https://iris.who.int/handle/10665/20750"